Volume 69 Received 9 November 2012 | ||||||||||
| ||||||||||
aUniversity of Mysore, Department of Studies in Chemistry, Manasagangotri, Mysore 570 006, India,bMangalore University, Department of Studies in Chemistry, Mangalagangotri 574 199, India, and cNelson Mandela Metropolitan University, Summerstrand Campus, Department of Chemistry, University Way, Summerstrand, PO Box 77000, Port Elizabeth, 6031, South Africa
Correspondence e-mail: richard.betz@webmail.co.za
In the title salt, C26H27F2N2+·C4H5O4-, the piperazine N atom bearing the vinylic substituent is protonated. The piperazine ring adopts a chair conformation. In ther crystal, the succinate monoanions are connected via short O-H
O hydrogen bonds between the carboxylic acid and carboxylate groups into undulating chains extending along [001] and the flunarizinium monocations are attached to these chains via N+-H
O- hydrogen bonds. C-H
O interactions connect these chains into a three-dimensional network. The shortest centroid-centroid distance of 3.7256 (10) Å was found between one of the fluorinated benzene rings and the non-fluorinated phenyl ring in the neighbouring molecule related by a glide plane.
For pharmaceutical properties of flunarizine, see: Holmes et al. (1984
); Amery (1983
) and of piperazine derivatives, see: Brockunier et al. (2004
); Bogatcheva et al. (2006
); Elliott (2011
). For related structures, see: Betz et al. (2011a
,b
); Dayananda et al. (2012a
,b
); Fillers & Hawkinson (1982
); Vanier & Brisse (1983
). For puckering analysis of six-membered rings, see: Cremer & Pople (1975
); Boeyens (1978
). For graph-set analysis of hydrogen bonds, see: Etter et al. (1990
); Bernstein et al. (1995
).
|
|
|
Data collection: APEX2 (Bruker, 2010
); cell refinement: SAINT (Bruker, 2010
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 (Farrugia, 2012
) and Mercury (Macrae et al., 2008
); software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: GK2534 ).
CNK thanks the University of Mysore for research facilities and the Principal of Maharani's Science College for Women for permission to do research.
Amery, W. K. (1983). Headache, 23, 70-74.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.
![[ISI]](../../../../../../logos/isiborder.gif)
Betz, R., Gerber, T., Hosten, E., Dayananda, A. S. & Yathirajan, H. S. (2011a). Acta Cryst. E67, o2783-o2784.
![[details]](../../../../../../e/graphics/details.gif)
Betz, R., Gerber, T., Hosten, E., Dayananda, A. S., Yathirajan, H. S. & Narayana, B. (2011b). Acta Cryst. E67, o2587-o2588.
![[details]](../../../../../../e/graphics/details.gif)
Boeyens, J. C. A. (1978). J. Cryst. Mol. Struct. 8, 317-320. ![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Bogatcheva, E., Hanrahan, C., Nikonenko, B., Samala, R., Chen, P., Gearhart, J., Barbosa, F., Einck, L., Nacy, C. A. & Protopopova, M. (2006). J. Med. Chem. 49, 3045-3048.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Brockunier, L. L., He, J., Colwell, L. F. Jr, Habulihaz, B., He, H., Leiting, B., Lyons, K. A., Marsilio, F., Patel, R. A., Teffera, Y., Wu, J. K., Thornberry, N. A., Weber, A. E. & Parmee, E. R. (2004). Bioorg. Med. Chem. Lett. 14, 4763-4766.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Bruker (2008). SADABS . Bruker Inc., Madison, Wisconsin, USA.
Bruker (2010). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.
![[ISI]](../../../../../../logos/isiborder.gif)
Dayananda, A. S., Dutkiewicz, G., Yathirajan, H. S., Ramesha, A. R. & Kubicki, M. (2012a). Acta Cryst. E68, o2817.
![[details]](../../../../../../e/graphics/details.gif)
Dayananda, A. S., Yathirajan, H. S., Keeley, A. C. & Jasinski, J. P. (2012b). Acta Cryst. E68, o2237.
![[details]](../../../../../../e/graphics/details.gif)
Elliott, S. (2011). Drug. Test. Anal. 3, 430-438.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Etter, M. C., MacDonald, J. C. & Bernstein, J. (1990). Acta Cryst. B46, 256-262.
![[details]](../../../../../../b/graphics/details.gif)
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
![[details]](../../../../../../j/graphics/details.gif)
Fillers, J. P. & Hawkinson, S. W. (1982). Acta Cryst. B38, 3041-3045.
![[details]](../../../../../../b/graphics/details.gif)
Holmes, B., Brogden, R. N., Heel, R. C., Speight, T. M. & Avery, G. S. (1984). Drugs, 27, 6-44.
![[ISI]](../../../../../../logos/isiborder.gif)
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.
![[details]](../../../../../../j/graphics/details.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Vanier, M. & Brisse, F. (1983). Acta Cryst. C39, 912-914.
![[details]](../../../../../../c/graphics/details.gif)